DES (Desmin) variants and mutations
DES (also known as Desmin) is a human protein-coding gene encoding a desmin protein. Its desmin filaments mechanically integrate sarcomeres with the nucleus, mitochondria, and cell junctions in striated muscle. Pathogenic variants cause desmin-related myopathy and can produce cardiomyopathy, conduction disease, and skeletal-muscle weakness. This analysis covers 1,292 DES variants and mutations. Of these, 10% have pathogenic or likely pathogenic clinical classifications, 89% have computational variant effect predictions from REVEL and MutPred, and 50% have population-specific frequency data. Disease context includes myofibrillar myopathy 1, Desminopathy, and dilated cardiomyopathy 1I. Example DES variants include M1T, M1V, and S2I.
Variant analysis overview
- Gene: DES
- Protein: Desmin
- UniProt accession: P17661
- Organism: Homo sapiens
- Variants analyzed: 1292
- Variant scope: all variants
- Completed: 2026-08-10
Variant and mutation evidence
- Variant composition: 869 unspecified-consequence records; 218 missense variants; 153 synonymous variants; 5 in-frame deletions; 26 frameshift variants; 15 stop-gained variants; 1 in-frame insertions; 5 substitution
- Clinical classifications: 133 pathogenic or likely pathogenic; 40 benign or likely benign; 515 uncertain-significance; 53 other clinical labels.
- Computational signals: 289 REVEL high-risk; 119 MutPred high-risk.
- Variant classes: 1,061 missense; 153 synonymous; 74 truncating or splice.
- Prediction scores: 1,145 variants have prediction scores (89% of the analyzed set).
- Literature: 40 publications are represented in the literature summary.
Clinical, disease, and population context
- Clinical evidence: 22 records have expert-only or criteria-backed evidence.
- Clinical annotations: 744 variants have clinical annotations.
- Population evidence: 979 variants have population-frequency evidence.
- Disease context: 25 disease associations are represented. Top associations: myofibrillar myopathy 1, Desminopathy, dilated cardiomyopathy 1I, neurogenic scapuloperoneal syndrome, Kaeser type, Autosomal recessive limb-girdle muscular dystrophy due to desmin deficiency, Scapuloperoneal amyotrophy, dilated cardiomyopathy, cardiomyopathy, Abnormality of the cardiovascular system, arrhythmogenic right ventricular cardiomyopathy, familial dilated cardiomyopathy, MFM1.
Protein structure and variant hotspots
- Protein features: 1 domains; 21 post-translational modification sites.
- Ancestry evidence: 642 variants have ancestry-specific frequency data.
- Structural context: 736 variants have structural context.
- PTM context: 70 variants overlap post-translational modification sites.
- 3D hotspots: 3 hotspot clusters were identified. Clusters at residues 74-80 (tolerant, 18 variants); residues 117-127 (intolerant, 16 variants); residues 167-181 (intolerant, 22 variants).
- Allosteric analysis: 1 functional sites were identified.
- gnomAD gene constraint: pLI 0.00 (tolerant of loss-of-function variation); LOEUF 0.62; missense Z-score 0.84.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable DES variants
Examples include M1T, M1V, S2I, S2N, S2S, S2R, Q3*, Q3E. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1T (p.Met1Thr), rs2125165615, ClinGen CA350681909, ClinVar RCV001377481, MetaLR 0.69, MetaSVM 0.51, Likely pathogenic, Desmin-related myofibrillar myopathy
- M1V (p.Met1Val), rs1057523274, ClinGen CA16604392, ClinVar RCV000417495, ClinVar RCV001217218, MetaLR 0.63, MetaSVM 0.37, Conflicting interpretations, not provided; Desmin-related myofibrillar myopathy; Cardiovascular phenotype
- S2I (p.Ser2Ile), rs58999456, ClinGen CA217078, ClinVar RCV000056804, ClinVar RCV000794180, REVEL 0.67, CADD 29.00, Pathogenic/Likely pathogenic, Desmin-related myofibrillar myopathy; Primary familial dilated cardiomyopathy; n
- S2N (p.Ser2Asn), gnomAD 2-219418467-G-A, REVEL 0.41, CADD 26.50
- S2S (p.Ser2Ser), gnomAD 2-219418468-C-T, CADD 15.70
- S2R (p.Ser2Arg), gnomAD 2-219418468-C-A, REVEL 0.51, CADD 25.90
- Q3* (p.Gln3Ter), rs1954358233, ClinGen CA350681964, ClinVar RCV001037267, ClinVar RCV003490014, CADD 37.00, Pathogenic
- Q3E (p.Gln3Glu), rs1954358233, ClinGen CA350681960, ClinVar RCV003405870, Uncertain significance, DES-related disorder
- Q3R (p.Gln3Arg), rs1954358286, ClinGen CA350681975, ClinVar RCV001325781, Ensembl rs1954358286, REVEL 0.26, CADD 22.70, Uncertain significance, Desmin-related myofibrillar myopathy
- Q3K (p.Gln3Lys), gnomAD 2-219418469-C-A, REVEL 0.21, CADD 18.30
- Q3Q (p.Gln3Gln), rs1262196309, gnomAD 2-219418471-G-A, CADD 14.10
- A4D (p.Ala4Asp), rs1231213195, ClinGen CA350682026, ClinVar RCV003042318, REVEL 0.26, CADD 22.70, Uncertain significance, Desmin-related myofibrillar myopathy
- A4G (p.Ala4Gly), gnomAD rs1231213195, REVEL 0.22, CADD 22.50
- A4T (p.Ala4Thr), rs1239304442, ClinGen CA350682006, ClinVar RCV001363051, TOPMed rs1239304442, REVEL 0.20, CADD 21.90, Uncertain significance, Desmin-related myofibrillar myopathy
- A4S (p.Ala4Ser), gnomAD 2-219418472-G-T, REVEL 0.14, CADD 20.20
- A4V (p.Ala4Val), gnomAD 2-219418473-C-T, REVEL 0.22, CADD 21.80
- A4A (p.Ala4Ala), rs762566962, gnomAD 2-219418474-C-A, CADD 15.80
- Y5* (p.Tyr5Ter), rs1322222685, ClinGen CA350682066, ClinVar RCV003214084, gnomAD rs1322222685, CADD 36.00, Uncertain significance
- Y5S (p.Tyr5Ser), Ensembl rs1954358625
- Y5H (p.Tyr5His), gnomAD 2-219418475-T-C, REVEL 0.32, CADD 24.90
- Y5C (p.Tyr5Cys), gnomAD 2-219418476-A-G, REVEL 0.32, CADD 24.50
- S6* (p.Ser6Ter), gnomAD rs1214936508, CADD 37.00, Uncertain significance
- S6L (p.Ser6Leu), rs1214936508, ClinGen CA350682084, ClinVar RCV000693314, gnomAD rs1214936508, REVEL 0.31, CADD 24.30, Uncertain significance, Cardiovascular phenotype; Desmin-related myofibrillar myopathy
- S6W (p.Ser6Trp), rs1214936508, ClinGen CA350682089, ClinVar RCV001962629, ClinVar RCV002407124, REVEL 0.81, CADD 27.90, Uncertain significance, Cardiovascular phenotype; Desmin-related myofibrillar myopathy
- S6S (p.Ser6Ser), rs199972656, gnomAD 2-219418480-G-A, CADD 13.60
- S7F (p.Ser7Phe), rs903985237, ClinGen CA65980518, ClinVar RCV000730386, UniProt VAR 067207, REVEL 0.56, CADD 26.90, Uncertain significance, not provided
- S8G (p.Ser8Gly), rs752174050, ClinGen CA2125003, ClinVar RCV002800305, ExAC rs752174050, REVEL 0.17, CADD 23.30, Uncertain significance, Desmin-related myofibrillar myopathy
- S8S (p.Ser8Ser), gnomAD 2-219418486-C-T, CADD 15.80
- Q9E (p.Gln9Glu), rs886044488, ClinGen CA10606821, ClinVar RCV000334577, Ensembl rs886044488, AlphaMissense 0.14, MetaLR 0.34, Uncertain significance, not provided
- Q9L (p.Gln9Leu), TOPMed rs1954359092
- Q9R (p.Gln9Arg), gnomAD 2-219418488-A-G, REVEL 0.42, CADD 22.90
- Q9H (p.Gln9His), gnomAD 2-219418489-G-T, REVEL 0.33, CADD 23.70
- R10C (p.Arg10Cys), rs1196125127, ClinGen CA350682181, ClinVar RCV001823813, ClinVar RCV001869824, REVEL 0.62, AlphaMissense 0.29, Uncertain significance, Desmin-related myofibrillar myopathy; not specified
- R10G (p.Arg10Gly), TOPMed rs1196125127, gnomAD rs1196125127, Uncertain significance
- R10H (p.Arg10His), rs757839952, ClinGen CA2125004, NCI-TCGA Cosmic COSV1009, ClinVar RCV001863643, REVEL 0.45, CADD 23.50, Uncertain significance, Desmin-related myofibrillar myopathy
- R10S (p.Arg10Ser), rs1196125127, ClinGen CA350682178, ClinVar RCV000651547, TOPMed rs1196125127, AlphaMissense 0.29, MetaLR 0.47, Uncertain significance, Desmin-related myofibrillar myopathy
- R10L (p.Arg10Leu), gnomAD 2-219418491-G-T, REVEL 0.34, CADD 24.20
- R10R (p.Arg10Arg), rs886042179, gnomAD 2-219418492-C-T, CADD 15.00
- V11A (p.Val11Ala), rs2545245505, ClinGen CA350682212, ClinVar RCV003801092, Uncertain significance, Desmin-related myofibrillar myopathy
- V11L (p.Val11Leu), rs1475120487, ClinGen CA350682207, ClinVar RCV003793505, REVEL 0.23, CADD 20.00, Uncertain significance, Desmin-related myofibrillar myopathy
- V11M (p.Val11Met), rs1475120487, ClinGen CA350682204, ClinVar RCV003794987, TOPMed rs1475120487, REVEL 0.26, CADD 22.30, Uncertain significance, Desmin-related myofibrillar myopathy
- S12F (p.Ser12Phe), rs267607495, ClinGen CA217069, ClinVar RCV000056800, ClinVar RCV000154600, REVEL 0.87, CADD 28.20, Pathogenic/Likely pathogenic, Desmin-related myofibrillar myopathy; DES-related desminopathy; Primary dilated
- S12P (p.Ser12Pro), ExAC rs768075842, TOPMed rs768075842, gnomAD rs768075842, REVEL 0.86, CADD 31.00
- S12S (p.Ser12Ser), gnomAD 2-219418498-C-A, CADD 14.30
- S13F (p.Ser13Phe), rs62636495, ClinGen CA261520, ClinVar RCV000037240, ClinVar RCV000056801, AlphaMissense 0.91, MetaLR 0.83, Pathogenic, Desmin-related myofibrillar myopathy; not provided; Primary dilated cardiomyopat
- S13P (p.Ser13Pro), rs1954359599, ClinGen CA350682267, ClinVar RCV001299265, ClinVar RCV003166680, AlphaMissense 0.87, MetaLR 0.79, Conflicting interpretations, Desmin-related myofibrillar myopathy; Autosomal dominant DES-related disorders
- S13Y (p.Ser13Tyr), rs62636495, ClinGen CA350682283, ClinVar RCV000651549, ClinVar RCV000730717, AlphaMissense 0.91, MetaLR 0.83, Uncertain significance, Desmin-related myofibrillar myopathy; not provided
- S13S (p.Ser13Ser), gnomAD 2-219418501-C-G, CADD 15.00
- Y14* (p.Tyr14Ter), Ensembl rs1954359860, CADD 37.00
- Y14H (p.Tyr14His), rs750819338, ClinGen CA2125006, ClinVar RCV001933052, ClinVar RCV002324326, REVEL 0.87, CADD 30.00, Uncertain significance, Cardiovascular phenotype; not provided; Desmin-related myofibrillar myopathy
- Y14S (p.Tyr14Ser), Ensembl rs2125165706, REVEL 0.92, CADD 32.00
- p.Tyr14 Thr17del, rs1954359744, gnomAD 2-219418499-TCCTA, CADD 22.60
- Y14T (p.Tyr14Thr), gnomAD 2-219418501-CT-C, CADD 28.70
- R15C (p.Arg15Cys), rs756390565, ClinGen CA2125008, ClinVar RCV001965707, ExAC rs756390565, REVEL 0.79, CADD 29.10, Uncertain significance, Desmin-related myofibrillar myopathy
- R15G (p.Arg15Gly), rs756390565, ClinGen CA2125007, ClinVar RCV003785797, ExAC rs756390565, REVEL 0.69, CADD 24.20, Uncertain significance, Desmin-related myofibrillar myopathy
- R15H (p.Arg15His), TOPMed rs962731426, gnomAD rs962731426, REVEL 0.50, CADD 24.60
- R15P (p.Arg15Pro), TOPMed rs962731426, gnomAD rs962731426, Uncertain significance, Cardiovascular phenotype
- R15S (p.Arg15Ser), rs756390565, ClinGen CA16622111, ClinVar RCV001903577, ClinVar RCV003146333, REVEL 0.61, CADD 24.10, Uncertain significance, Desmin-related myofibrillar myopathy; not provided
- R15L (p.Arg15Leu), gnomAD 2-219418506-G-T, REVEL 0.58, CADD 24.50
- R15R (p.Arg15Arg), gnomAD 2-219418507-C-A, CADD 15.50
- R16C (p.Arg16Cys), rs60798368, ClinGen CA217072, ClinVar RCV000056802, ClinVar RCV000239680, REVEL 0.90, AlphaMissense 0.97, Conflicting interpretations, Desmin-related myofibrillar myopathy; not provided
- R16H (p.Arg16His), NCI-TCGA Cosmic COSV6466, REVEL 0.83, CADD 32.00, Variant assessed as somatic; moderate impact., in MFM1
- R16S (p.Arg16Ser), rs60798368, ClinGen CA350682339, ClinVar RCV001867087, TOPMed rs60798368, AlphaMissense 0.97, MetaLR 0.85, Uncertain significance, Desmin-related myofibrillar myopathy
- R16L (p.Arg16Leu), gnomAD 2-219418509-G-T, REVEL 0.93, CADD 32.00
- R16R (p.Arg16Arg), gnomAD 2-219418510-C-A, CADD 15.20
- T17N (p.Thr17Asn), rs1954360300, ClinGen CA350682384, ClinVar RCV001339441, Ensembl rs1954360300, REVEL 0.32, CADD 20.90, Uncertain significance, Desmin-related myofibrillar myopathy
- T17P (p.Thr17Pro), rs1342928312, ClinGen CA350682368, ClinVar RCV003033579, AlphaMissense 0.17, MetaLR 0.34, Uncertain significance, Desmin-related myofibrillar myopathy
- T17S (p.Thr17Ser), rs1342928312, ClinGen CA350682380, ClinVar RCV001997968, TOPMed rs1342928312, REVEL 0.27, AlphaMissense 0.17, Uncertain significance, Desmin-related myofibrillar myopathy
- T17T (p.Thr17Thr), gnomAD 2-219418513-C-A, CADD 13.70
- F18L (p.Phe18Leu), TOPMed rs1420981881, gnomAD rs1420981881, REVEL 0.55, CADD 22.70, Likely benign
- F18del (p.Phe18del), gnomAD 2-219418512-CCTT-, CADD 21.60
- F18S (p.Phe18Ser), gnomAD 2-219418513-CT-C, CADD 27.40
- F18I (p.Phe18Ile), gnomAD 2-219418514-T-A, REVEL 0.82, CADD 24.90
- F18F (p.Phe18Phe), rs1420981881, gnomAD 2-219418516-C-T, CADD 14.60
- G19R (p.Gly19Arg), rs936853024, ClinGen CA65980591, ClinVar RCV000595015, ClinVar RCV000697037, REVEL 0.90, CADD 27.90, Uncertain significance, Desmin-related myofibrillar myopathy; Cardiovascular phenotype; not provided
- G19S (p.Gly19Ser), NCI-TCGA TCGA novel, TOPMed rs936853024, gnomAD rs936853024, REVEL 0.74, CADD 27.50, Uncertain significance
- G19A (p.Gly19Ala), gnomAD 2-219418517-GGCGG, CADD 29.90
- G19V (p.Gly19Val), gnomAD 2-219418518-G-T, REVEL 0.90, CADD 27.40
- G19G (p.Gly19Gly), rs1354406363, gnomAD 2-219418519-C-T, CADD 10.80
- G20E (p.Gly20Glu), rs2125165738, ClinGen CA350682451, ClinVar RCV001937089, Ensembl rs2125165738, REVEL 0.48, CADD 21.80, Uncertain significance, Desmin-related myofibrillar myopathy
- G20R (p.Gly20Arg), rs759306707, ClinGen CA16610716, ClinVar RCV000461350, TOPMed rs759306707, REVEL 0.50, CADD 24.30, Uncertain significance, Desmin-related myofibrillar myopathy
- G20W (p.Gly20Trp), gnomAD 2-219418520-G-T, REVEL 0.61, CADD 28.30
- G20V (p.Gly20Val), gnomAD 2-219418521-G-T, REVEL 0.48, CADD 23.20
- G20G (p.Gly20Gly), rs1058253, gnomAD 2-219418522-G-A, CADD 7.57
- A21D (p.Ala21Asp), rs755107287, ClinGen CA350682495, ClinVar RCV001057700, ExAC rs755107287, REVEL 0.40, CADD 13.20, Uncertain significance, Desmin-related myofibrillar myopathy
- A21P (p.Ala21Pro), ExAC rs749447320, gnomAD rs749447320, REVEL 0.38, CADD 16.70, Uncertain significance
- A21T (p.Ala21Thr), rs749447320, ClinGen CA2125009, ClinVar RCV003146045, ClinVar RCV003778860, REVEL 0.23, CADD 18.40, Uncertain significance, Desmin-related myofibrillar myopathy; not provided
- A21V (p.Ala21Val), ExAC rs755107287, TOPMed rs755107287, gnomAD rs755107287, REVEL 0.22, CADD 13.70, Uncertain significance
- A21A (p.Ala21Ala), rs201458068, gnomAD 2-219418525-C-T, CADD 9.51
- P22L (p.Pro22Leu), 1000Genomes rs748158450, ExAC rs748158450, TOPMed rs748158450, gnomAD rs748158450, REVEL 0.18, CADD 15.60, Uncertain significance, Desmin-related myofibrillar myopathy
- P22R (p.Pro22Arg), rs748158450, ClinGen CA2125012, ClinVar RCV000818028, ClinVar RCV002478908, REVEL 0.28, CADD 15.20, Uncertain significance, Cardiovascular phenotype; Dilated cardiomyopathy 1I; Neurogenic scapuloperoneal
- P22S (p.Pro22Ser), gnomAD 2-219418526-C-T, REVEL 0.07, CADD 11.40
- P22Q (p.Pro22Gln), gnomAD 2-219418527-C-A, REVEL 0.24, CADD 18.20
- P22P (p.Pro22Pro), rs767502653, gnomAD 2-219418528-G-A, CADD 6.47
- G23A (p.Gly23Ala), rs3903257, ClinGen CA350682602, ClinVar RCV003788115, ExAC rs3903257, REVEL 0.14, CADD 14.90, Uncertain significance, Desmin-related myofibrillar myopathy
- G23D (p.Gly23Asp), rs3903257, ClinGen CA2125014, ClinVar RCV003196286, ClinVar RCV003779622, REVEL 0.27, CADD 17.60, Uncertain significance, Cardiovascular phenotype; Desmin-related myofibrillar myopathy
- G23V (p.Gly23Val), ExAC rs3903257, gnomAD rs3903257, REVEL 0.16, CADD 16.90, Uncertain significance
- G23C (p.Gly23Cys), gnomAD 2-219418529-G-T, REVEL 0.37, CADD 13.60
- G23G (p.Gly23Gly), gnomAD 2-219418531-C-A, CADD 13.20
- F24L (p.Phe24Leu), gnomAD 2-219418523-G-GC, CADD 23.70
- p.Phe24 Gly27del, gnomAD 2-219418528-GGGCT, CADD 20.20
- P25=, rs1318299, ClinVar RCV000154433, Benign
- P25A (p.Pro25Ala), rs1485482974, ClinGen CA350682640, ClinVar RCV003804546, AlphaMissense 0.05, MetaLR 0.26, Uncertain significance, Desmin-related myofibrillar myopathy
- P25Q (p.Pro25Gln), ExAC rs745708897, REVEL 0.19, CADD 16.50
- P25S (p.Pro25Ser), gnomAD rs1485482974
- P25L (p.Pro25Leu), gnomAD 2-219418536-C-T, REVEL 0.16, CADD 15.30
- P25R (p.Pro25Arg), gnomAD 2-219418536-C-G, REVEL 0.21, CADD 15.70
- P25P (p.Pro25Pro), rs1318299, gnomAD 2-219418537-A-G, CADD 13.40
- L26H (p.Leu26His), rs1064796529, ClinGen CA16617476, ClinVar RCV000478316, ClinVar RCV000766356, REVEL 0.28, CADD 21.80, Uncertain significance, Desmin-related myofibrillar myopathy; not specified; not provided
- L26I (p.Leu26Ile), gnomAD 2-219418538-C-A, REVEL 0.13, CADD 14.10
- L26P (p.Leu26Pro), gnomAD 2-219418539-T-C, REVEL 0.19, CADD 19.10
- L26L (p.Leu26Leu), rs1252527107, gnomAD 2-219418540-C-T, CADD 8.06
- G27D (p.Gly27Asp), rs1575012966, ClinGen CA350682712, ClinVar RCV000799121, Ensembl rs1575012966, REVEL 0.38, CADD 22.30, Uncertain significance, Desmin-related myofibrillar myopathy
- G27R (p.Gly27Arg), rs727504877, ClinGen CA350682707, ClinVar RCV001911879, TOPMed rs727504877, REVEL 0.38, CADD 23.20, Uncertain significance, Desmin-related myofibrillar myopathy
- G27S (p.Gly27Ser), rs727504877, ClinGen CA184448, ClinVar RCV000156244, ClinVar RCV000700537, REVEL 0.32, CADD 22.30, Uncertain significance, Cardiovascular phenotype; Desmin-related myofibrillar myopathy; not specified
- G27V (p.Gly27Val), gnomAD 2-219418542-G-T, REVEL 0.33, CADD 22.20
- G27G (p.Gly27Gly), gnomAD 2-219418543-C-A, CADD 13.10
- S28F (p.Ser28Phe), rs1954361986, ClinGen CA350682745, ClinVar RCV001594450, ClinVar RCV002437062, REVEL 0.64, CADD 27.30, Uncertain significance, Cardiovascular phenotype
- S28P (p.Ser28Pro), gnomAD 2-219418544-T-C, REVEL 0.58, CADD 25.10
- S28Y (p.Ser28Tyr), gnomAD 2-219418545-C-A, REVEL 0.65, CADD 24.40
- S28S (p.Ser28Ser), rs1177199218, gnomAD 2-219418546-C-A, CADD 14.30
- P29L (p.Pro29Leu), rs1378987625, ClinGen CA350682752, ClinVar RCV001056471, gnomAD rs1378987625, REVEL 0.39, CADD 22.30, Uncertain significance, Desmin-related myofibrillar myopathy
- P29R (p.Pro29Arg), rs1378987625, ClinGen CA350682749, ClinVar RCV003085956, REVEL 0.28, CADD 21.90, Uncertain significance, Desmin-related myofibrillar myopathy
- P29T (p.Pro29Thr), gnomAD 2-219418547-C-A, REVEL 0.32, CADD 20.90
- P29S (p.Pro29Ser), gnomAD 2-219418547-C-T, REVEL 0.24, CADD 18.70
- P29Q (p.Pro29Gln), gnomAD 2-219418548-C-A, REVEL 0.35, CADD 22.50
- P29P (p.Pro29Pro), rs2125165803, gnomAD 2-219418549-G-T, CADD 14.30
- p.Leu30 Pro36del, gnomAD 2-219418545-CCCCG, CADD 22.10
- L30M (p.Leu30Met), gnomAD 2-219418550-C-A, REVEL 0.23, CADD 23.00
- L30P (p.Leu30Pro), gnomAD 2-219418551-T-C, REVEL 0.46, CADD 23.60
- S31=, rs2017800, ClinVar RCV000154434, AlphaMissense 0.50, MetaLR 0.41, Benign
- S31C (p.Ser31Cys), rs1553603207, ClinGen CA350682818, ClinVar RCV000592042, ClinVar RCV005223032, REVEL 0.31, CADD 21.90, Uncertain significance, Desmin-related myofibrillar myopathy; not provided
- S31N (p.Ser31Asn), gnomAD rs892698652, REVEL 0.24, CADD 22.10
- S31R (p.Ser31Arg), rs2017800, 1000Genomes rs2017800, ESP rs2017800, ExAC rs2017800, REVEL 0.35, AlphaMissense 0.50, Uncertain significance, Desmin-related myofibrillar myopathy; Dilated cardiomyopathy 1I; Neurogenic scap
- S31I (p.Ser31Ile), gnomAD 2-219418554-G-T, REVEL 0.30, CADD 22.60
- S31S (p.Ser31Ser), rs2017800, gnomAD 2-219418555-T-C, AlphaMissense 0.50, MetaLR 0.41
- S32L (p.Ser32Leu), gnomAD 2-219418557-C-T, REVEL 0.62, CADD 27.40
- S32* (p.Ser32Ter), gnomAD 2-219418557-C-A, CADD 39.00
- S32S (p.Ser32Ser), gnomAD 2-219418558-G-C, CADD 12.90
- P33S (p.Pro33Ser), rs886042942, ClinGen CA10604899, ClinVar RCV000355468, Ensembl rs886042942, AlphaMissense 0.07, MetaLR 0.33, Uncertain significance, not provided
- P33L (p.Pro33Leu), gnomAD 2-219418560-C-T, REVEL 0.35, CADD 23.00
- P33H (p.Pro33His), gnomAD 2-219418560-C-A, REVEL 0.35, CADD 24.30
- P33P (p.Pro33Pro), gnomAD 2-219418561-C-A, CADD 9.72
- V34M (p.Val34Met), rs761354307, ClinGen CA2125019, ClinVar RCV002599977, ClinVar RCV003143505, REVEL 0.16, CADD 22.20, Uncertain significance, not provided; Desmin-related myofibrillar myopathy
- V34L (p.Val34Leu), gnomAD 2-219418562-G-T, REVEL 0.12, CADD 18.80
- F35I (p.Phe35Ile), 1000Genomes rs2125165836, REVEL 0.36, CADD 22.70
- F35L (p.Phe35Leu), rs768166041, ClinGen CA350682917, ClinVar RCV001896521, ClinVar RCV003146313, REVEL 0.18, CADD 22.50, Uncertain significance, Desmin-related myofibrillar myopathy
- F35S (p.Phe35Ser), rs1575012999, NCI-TCGA TCGA novel, ClinGen CA350682911, ClinVar RCV000809941, AlphaMissense 0.24, MetaLR 0.26, Uncertain significance, Desmin-related myofibrillar myopathy
- F35V (p.Phe35Val), gnomAD 2-219418565-T-G, REVEL 0.46, CADD 22.60
- P36R (p.Pro36Arg), ExAC rs750861089, gnomAD rs750861089, REVEL 0.42, CADD 22.50
- P36S (p.Pro36Ser), rs1954363029, ClinGen CA350682940, ClinVar RCV002972078, TOPMed rs1954363029, REVEL 0.19, CADD 16.90, Uncertain significance, Desmin-related myofibrillar myopathy
- P36T (p.Pro36Thr), NCI-TCGA TCGA novel, REVEL 0.40, CADD 17.40, Variant assessed as somatic; moderate impact.
- P36L (p.Pro36Leu), gnomAD 2-219418569-C-T, REVEL 0.28, CADD 18.00
- P36Q (p.Pro36Gln), gnomAD 2-219418569-C-A, REVEL 0.34, CADD 22.60
- P36P (p.Pro36Pro), rs1575013004, gnomAD 2-219418570-G-A, CADD 8.54
- R37G (p.Arg37Gly), rs537881554, ClinGen CA2125023, ClinVar RCV000481772, ClinVar RCV001203491, REVEL 0.39, CADD 20.30, Uncertain significance, Cardiovascular phenotype; not provided; Desmin-related myofibrillar myopathy
- R37L (p.Arg37Leu), rs1954363342, ClinGen CA350682944, ClinVar RCV001241290, Ensembl rs1954363342, REVEL 0.54, CADD 20.70, Uncertain significance, Desmin-related myofibrillar myopathy
- R37W (p.Arg37Trp), rs537881554, ClinGen CA2125022, ClinVar RCV000250161, ClinVar RCV000594311, REVEL 0.50, CADD 23.70, Uncertain significance, not specified; not provided; Desmin-related myofibrillar myopathy
- R37C (p.Arg37Cys), gnomAD 2-219418558-G-GCC, CADD 28.70
- R37R (p.Arg37Arg), gnomAD 2-219418571-C-A, CADD 13.70
- A38E (p.Ala38Glu), ExAC rs779049308, REVEL 0.45, CADD 21.10
- A38T (p.Ala38Thr), ExAC rs755197219, gnomAD rs755197219, REVEL 0.11, CADD 17.40, Uncertain significance, Cardiovascular phenotype; Desmin-related myofibrillar myopathy
- A38R (p.Ala38Arg), rs2125165857, gnomAD 2-219418571-CG-C, CADD 23.90
- A38S (p.Ala38Ser), gnomAD 2-219418574-G-T, REVEL 0.12, CADD 13.20
- A38V (p.Ala38Val), gnomAD 2-219418575-C-T, REVEL 0.19, CADD 20.80
- A38A (p.Ala38Ala), gnomAD 2-219418576-G-C, CADD 10.50
- G39A (p.Gly39Ala), ExAC rs781231410, TOPMed rs781231410, gnomAD rs781231410, Uncertain significance, Desmin-related myofibrillar myopathy
- G39D (p.Gly39Asp), ExAC rs781231410, TOPMed rs781231410, gnomAD rs781231410, REVEL 0.51, CADD 22.60, Uncertain significance, Desmin-related myofibrillar myopathy
- G39S (p.Gly39Ser), rs758434755, ClinGen CA2125027, ClinVar RCV001360576, ClinVar RCV003298568, REVEL 0.16, CADD 17.80, Uncertain significance, Cardiovascular phenotype; Desmin-related myofibrillar myopathy
- G39C (p.Gly39Cys), gnomAD 2-219418577-G-T, REVEL 0.45, CADD 23.80
- G39G (p.Gly39Gly), rs796885355, gnomAD 2-219418579-T-G, CADD 14.70
- F40S (p.Phe40Ser), rs2545246010, ClinGen CA350683030, ClinVar RCV003237203, Uncertain significance, not provided
- F40L (p.Phe40Leu), gnomAD 2-219418580-T-C, REVEL 0.22, CADD 22.40
- F40C (p.Phe40Cys), gnomAD 2-219418581-T-G, REVEL 0.51, CADD 24.30
- F40F (p.Phe40Phe), rs1954363921, gnomAD 2-219418582-C-T, CADD 12.40
- G41R (p.Gly41Arg), rs2545246000, ClinGen CA2740096471, ClinVar RCV003808417, Pathogenic
- G41S (p.Gly41Ser), ExAC rs745773759, gnomAD rs745773759, REVEL 0.43, CADD 21.60
- G41V (p.Gly41Val), NCI-TCGA Cosmic COSV6466, REVEL 0.59, CADD 23.90, Variant assessed as somatic; moderate impact.
- G41A (p.Gly41Ala), gnomAD 2-219418582-CG-C, CADD 28.60
- G41C (p.Gly41Cys), gnomAD 2-219418583-G-T, REVEL 0.66, CADD 25.00
Public DES analysis runs
- DES analysis run — DES (1,292 variants) — completed 2026-08-10